Jointown(SH:600998) Jing Ji Guan Cha Wang·2025-10-27 13:44Core Viewpoint - 九州通 continues to demonstrate steady growth with a strong performance in its Q3 2025 report, achieving revenue and net profit increases, driven by its strategic focus on new products, new retail, new medical services, digitalization, and real estate securitization [1][2]. Financial Performance - In the first three quarters of 2025, 九州通 reported revenue of 119.33 billion yuan, a year-on-year increase of 5.20%, and a net profit attributable to shareholders of 1.975 billion yuan, up 16.46% [1]. Core Business Growth - The company has successfully implemented its strategy focusing on new products, new retail, new medical services, digitalization, and real estate securitization, leading to stable development across its main business sectors [2]. - The total sales revenue from brand promotion (including pharmaceuticals and medical devices) reached 14.73 billion yuan, with pharmaceutical promotion revenue growing by 15.26% to 8.74 billion yuan [2]. New Retail Strategy - 九州通 has established a comprehensive new retail service system, integrating B2C and B2B e-commerce platforms, with a total of 33,275 stores by the end of Q3 2025, and sales to franchise stores reaching 5.40 billion yuan, a 43.40% increase [3]. New Medical Strategy - The company has expanded its clinic membership to over 3,000 and plans to establish a network of 10,000 clinics within three years, while also launching a SaaS system for clinic management [3][4]. Digitalization and AI Development - 九州通 has invested significantly in AI and digital capabilities, with R&D expenditures of 229 million yuan and a workforce of 1,591 technical personnel, focusing on various digital applications to enhance operational efficiency [4][5]. Real Estate Securitization (REITs) - The company's REIT product has performed well since its launch in February 2025, earning recognition as one of the most favored public REIT products by investors [6]. Emerging Business Growth - The traditional Chinese medicine segment reported sales of 4.51 billion yuan, a 26.08% increase, supported by investments in resource management and production capabilities [7]. - The medical beauty segment achieved sales of 904 million yuan, growing by 45.84%, with a network of 11,538 service institutions [8]. Logistics and Supply Chain Solutions - 九州通 has developed a nationwide intelligent pharmaceutical logistics network, covering 96% of regions, with 137 modern logistics centers totaling 4.02 million square meters [9]. - The company offers integrated smart supply chain solutions, enhancing logistics efficiency and service quality across various industries [10].